3003 ORAL Cetuximab plus irinotecan in patients (pts) with metastatic colorectal cancer (mCRC) failing prior oxaliplatin-based therapy: the EPIC trial
作者： W. Scheithauer , A. Sobrero , H.J. Lenz , J. Maurel , M. Lutz
DOI: 10.1016/S1359-6349(07)70931-X
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(0)